Prevention of hypoxic pulmonary hypertension by hypoxia-inducible expression of p27 in pulmonary artery smooth muscle cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Gene Therapy

• Publication date

  2014-05-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/gt.2014.49PMID 24871579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypoxia as a target for tissue specific gene therapy.

  2013cited by this paper
• Tanshinone IIA Inhibits Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation via Akt/Skp2/p27-Associated Pathway

  2013cited by this paper
• Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension.

  2012cited by this paper
• An essential role of p27 downregulation in fenvalerate-induced cell growth in human uterine leiomyoma and smooth muscle cells.

  2012cited by this paper
• Targeted gene delivery of BMPR2 attenuates pulmonary hypertension

  2011cited by this paper
• Heparin inhibits pulmonary artery smooth muscle cell proliferation through guanine nucleotide exchange factor-H1/RhoA/Rho kinase/p27.

  2011cited by this paper
• Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury

  2011cited by this paper
• Isolation and Culture of Pulmonary Endothelial Cells from Neonatal Mice

  2010cited by this paper
• Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia

  2010cited by this paper
• Tension Measurement in Isolated Rat and Mouse Pulmonary Artery.

  2010cited by this paper
• Effects of sodium tanshinone II A sulphonate on hypoxic pulmonary hypertension in rats in vivo and on Kv2.1 expression in pulmonary artery smooth muscle cells in vitro.

  2009cited by this paper
• Prevention of Pulmonary Hypertension by Angiotensin-Converting Enzyme 2 Gene Transfer

  2009cited by this paper
• Gene expression of cyclin‐dependent kinase inhibitors and effect of heparin on the expression in mice with hypoxia‐induced pulmonary hypertension

  2006cited by this paper
• Cyclin-Dependent Kinase Inhibitor p27Kip1, But Not p21WAF1/Cip1, Is Required for Inhibition of Hypoxia-Induced Pulmonary Hypertension and Remodeling by Heparin in Mice

  2005cited by this paper
• Isolation of highly pure alveolar epithelial type I and type II cells from rat lungs

  2005cited by this paper
• Cell cycle regulation in hematopoietic stem/progenitor cells.

  2004cited by this paper
• BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia.

  2004cited by this paper
• Isolation of highly pure alveolar epithelial type I and type II cells from rat lungs

  2004cited by this paper
• p27Kip1 Is Important in Modulating Pulmonary Artery Smooth Muscle Cell Proliferation

  2001cited by this paper
• Overexpression of p27Kip1 by doxycycline‐regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis

  2001cited by this paper
• p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation.

  2001cited by this paper
• eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis.

  2000cited by this paper
• Inhibition of Vascular Smooth Muscle Cell Proliferation by Sodium Salicylate Mediated by Upregulation of p21Waf1 and p27Kip1

  2000cited by this paper
• Development of a hypoxia-responsive vector for tumor-specific gene therapy

  2000cited by this paper
• Targeting gene expression to hypoxic tumor cells

  1997cited by this paper

• Mechanism of KLF2 in young mice with pneumonia induced by Streptococcus pneumoniae

  2024cites this paper
• Loss of Prolyl Hydroxylase 1 and 2 in SM22α-Expressing Cells Prevents Hypoxia-Induced Pulmonary Hypertension.

  2023cites this paper
• Biomimetic Nanoparticle-Mediated Target Delivery of Hypoxia-Responsive Plasmid of Angiotensin-Converting Enzyme 2 to Reverse Hypoxic Pulmonary Hypertension.

  2023cites this paper
• The substitution of SERCA2 redox cysteine 674 promotes pulmonary vascular remodeling by activating IRE1α/XBP1s pathway

  2022cites this paper
• Reversal of Hypoxic Pulmonary Hypertension by Hypoxia-Inducible Overexpression of Angiotensin-(1-7) in Pulmonary Endothelial Cells

  2020cites this paper
• Participation of PLK1 and FOXM1 in the hyperplastic proliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension

  2019cites this paper
• Resveratrol as a potential therapeutic drug for respiratory system diseases

  2017cites this paper
• Resveratrol as a potential therapeutic drug for respiratory system diseases

  2017cites this paper
• Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension

  2016cites this paper
• miR-29a-3p Attenuates Hypoxic Pulmonary Hypertension by Inhibiting Pulmonary Adventitial Fibroblast Activation

  2015cites this paper
• NSFC spurs significant basic research progress of respiratory medicine in China

  2015cites this paper